The risk of venous thromboembolism in early pregnancy loss: Review of the literature and current guidelines and the need for guidance - Communication from the SSC on Women's Health Issues for thrombosis and haemostasis.
early pregnancy loss
guidelines
review
venous thromboembolism risk
Journal
Journal of thrombosis and haemostasis : JTH
ISSN: 1538-7836
Titre abrégé: J Thromb Haemost
Pays: England
ID NLM: 101170508
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
revised:
04
12
2021
received:
14
05
2021
accepted:
07
12
2021
pubmed:
14
12
2021
medline:
16
3
2022
entrez:
13
12
2021
Statut:
ppublish
Résumé
Thromboembolic disease is one of the major causes of mortality and morbidity in pregnancy and the puerperium, with 1 death per 100 000 births attributed to venous thromboembolism (VTE). Factors associated with development of thrombosis are all present in pregnancy, with some of these changes seen from conception. Given how common early pregnancy loss is, the aim of this review is to evaluate the uncertainty surrounding the risk of VTE following early pregnancy loss and termination of pregnancy. A structured literature search was conducted to identify existing evidence as well as international pregnancy-specific guidelines regarding assessment and prevention of VTE risk in pregnant women. This review was reviewed, critiqued, and approved by all members of the International Society on Thrombosis and Haemostasis subcommittee for Women's Health Issues in Thrombosis and Haemostasis. Four published original research studies, one clinical comment paper, and six guidelines were reviewed. Despite clear evidence of the increased risk of VTE in pregnancy, there is a lack of guidance regarding evaluation and management after early pregnancy loss. International collaborative research to determine the risk of VTE and its prevention in women undergoing surgical termination of pregnancy or following surgical management of early pregnancy loss is urgently needed. Pregnancy-specific risk assessment taking into account preexisting risk factors is advocated. Education of health care professionals involved in early pregnancy care and guidance on management, albeit based on limited existing evidence, are necessary to highlight the need for individualized care.
Sections du résumé
BACKGROUND
Thromboembolic disease is one of the major causes of mortality and morbidity in pregnancy and the puerperium, with 1 death per 100 000 births attributed to venous thromboembolism (VTE). Factors associated with development of thrombosis are all present in pregnancy, with some of these changes seen from conception.
OBJECTIVE
Given how common early pregnancy loss is, the aim of this review is to evaluate the uncertainty surrounding the risk of VTE following early pregnancy loss and termination of pregnancy.
METHODS
A structured literature search was conducted to identify existing evidence as well as international pregnancy-specific guidelines regarding assessment and prevention of VTE risk in pregnant women. This review was reviewed, critiqued, and approved by all members of the International Society on Thrombosis and Haemostasis subcommittee for Women's Health Issues in Thrombosis and Haemostasis.
RESULTS
Four published original research studies, one clinical comment paper, and six guidelines were reviewed. Despite clear evidence of the increased risk of VTE in pregnancy, there is a lack of guidance regarding evaluation and management after early pregnancy loss.
CONCLUSION
International collaborative research to determine the risk of VTE and its prevention in women undergoing surgical termination of pregnancy or following surgical management of early pregnancy loss is urgently needed. Pregnancy-specific risk assessment taking into account preexisting risk factors is advocated. Education of health care professionals involved in early pregnancy care and guidance on management, albeit based on limited existing evidence, are necessary to highlight the need for individualized care.
Identifiants
pubmed: 34897975
doi: 10.1111/jth.15621
pii: S1538-7836(22)00073-3
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
767-776Informations de copyright
© 2021 International Society on Thrombosis and Haemostasis.
Références
Bauersachs RM, Dudenhausen J, Faridi A, et al. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost. 2007;98:1237-1245.
James AH. Pregnancy-associated thrombosis. Hematology. 2009;2009(1):277-285.
Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143:697-706.
Liang Z-W, Gao W-L, Feng L-M, et al. Clinical characteristics and prognosis of cerebral venous thrombosis in Chinese women during pregnancy and puerperium. Sci Rep. 2017;7:43866.
MBRRACE-UK Saving Lives. Improving Mothers’ Care, 2018. Lessons learned to inform future maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity.
Creanga AA, Syverson C, Seed K, Callaghan WM. Pregnancy-related mortality in the United States, 2011-2013. Obstet Gynecol. 2017;130:366-373.
Australian Institute of Health and Welfare 2018. Maternal deaths in Australia 2016. Cat. no. PER 99. AIHW. Viewed 06 September 2019, https://www.aihw.gov.au/reports/mothers-babies/maternal-deaths-in-australia-2016
Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008;6(4):632-637.
Moodley J, Fawcus F, Pattison R. Improvements in maternal mortality in South Africa. South Afr Med J. [S.l.], p. s4-s8, mar. 2018. ISSN 2078-5135. Available at: http://www.samj.org.za/index.php/samj/article/view/12244/8428 Date accessed: 27 Jan 2021
James AH. MPH prevention and management of venous thromboembolism in pregnancy. Am J Med. 2007;120(10B):S26-S34.
Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003;16(2):153-168.
Davor J, Caroline O, Ruth B-A. Diagnosis and management of first trimester miscarriage. BMJ. 2013;346:f3676.
Bottomley C. Epidemiology and aetiology of miscarriage and ectopic pregnancy. In: Jurkovic D, Farquharson R, eds. Acute Gynaecology and Early Pregnancy, Chapter 2. London: RCOG Press; 2011.
Abortion Statistics, England and Wales. 2017 Summary information from the abortion notification forms returned to the Chief Medical Officers of England and Wales Department of Health and Social Care. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/763174/2017-abortion-statistics-for-england-and-wales-revised.pdf
Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L. Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ. 2006;332(7552):1235-1240.
Thrombosis and Embolism during Pregnancy and the Puerperium, Reducing the Risk (Green-top Guideline No. 37a). 2015.
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing, NICE guideline, [NG158], March 2020. National Institute for Health and Care Excellence (NICE).
Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos A-M, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy. Chest. 2012;141(2):e691S-e736S.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10:89.
Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in me- ta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp Accessed: August 2021
Niinimäki M, Pouta A, Bloigu A, et al. Immediate complications after medical compared with surgical termination of pregnancy. Obstet Gynecol. 2009;114(4):795-804.
Rey E, Qc M, Kent N, Bc V, Corbett T, Ab E, David M, Montreal Q, Douglas M, Ab C, Magee L, Rodger M, On O, Smith R, Bc V. SOGC Clinical Practice Guideline Venous Thromboembolism and Antithrombotic Therapy in Pregnancy VTE in Pregnancy Guideline Working Group. 308. 2014.
ESHRE Capri Workshop Group, Eichinger S, Evers JLH, et al. Venous thromboembolism in women: a specific reproductive health risk. Hum Reprod Update. 2013;19(5):471-482.
Liu N, Vigod SN, Farrugia MM, Urquia ML, Ray JG. Venous thromboembolism after induced abortion: a population-based, propensity-score-matched cohort study in Canada. Lancet Haematol. 2018;5(7):e279-e288.
Middeldorp S, Ankum WM. Venous thromboembolism after induced abortion: the shorter the pregnancy, the lower the risk? Lancet Haematol. 2018;5(7):e271-e272
Hansen AT, Juul S, Knudsen UB, Hvas AM. Low risk of venous thromboembolism following early pregnancy loss in pregnancies conceived by IVF. Hum Reprod. 2018;33(10):1968-1972.
Petersen JF, Bergholt T, Nielsen AK, Paidas MJ, Løkkegaard ECL. Combined hormonal contraception and risk of venous thromboembolism within the first year following pregnancy Danish nationwide historical cohort 1995-2009. Thromb Haemost. 2014;112(1):1995-2009.
Queensland Clinical Guideline. VTE prophylaxis in pregnancy and the puerperium, 2014.
Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and HSE Clinical Care Programme in Obstetrics and Gynaecology and Irish Haematology Society. Clinical practice guideline venous thromboprophylaxis in pregnancy, 2013.
Lindqvist P, Hellgren M. Obstetric thromboprophylaxis: the swedish guidelines. Adv Hematol. 2011;2011:157483.
Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2(22):3317-3359.